A novel aspect of imprinting: higher maternal expression of Gαs in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart.
Introduction
The human GNAS gene is located on chromosome 20q13.2-13.3 and expression of GNAS products is regulated both by imprinting and alternative splicing . Usage of alternative promoters and first exons that splice onto a common exon (exon 2) results in multiple gene products.
The ubiquitously expressed G-protein α-subunit Gαs is generated by the most downstream promoter and mediates stimulation of adenylyl cyclase and the production of the second-messenger cyclic AMP (cAMP) via a number of receptor types, e.g. β 1 -and β 2 -adrenoreceptors. Cyclic AMP subsequently activates protein kinase A (PKA) which catalyzes the phosphorylation of various proteins important for cellular signaling.
The Gαs protein consists of 13 exons and there exist four splice variants differing by inclusion (long form) or exclusion (short form) of exon 3, with both forms being differentially expressed in various tissues . Gαs is imprinted in a tissue-specific manner, being expressed primarily from the maternal allele in pituitary, thyroid, renal proximal tubules, gonads and the paraventricular nucleus of the hypothalamus, but is believed to be biallelically expressed with an equal contribution of the maternal and paternal allele in most tissues Germain-Lee et al., 2002; Mantovani et al., 2002; Liu et al., 2003; Chen et al., 2009; Yu et al., 1998) .
Heterozygous inactivating GNAS mutations result in Albright hereditary osteodystrophy (AHO) with maternal inheritance of AHO also leading to multihormone resistance [pseudohypoparathyroidism type 1a (PHP1A)] and paternal inheritance leading to AHO alone (pseudopseudohypoparathyroidism ) (Yu et al., 1998; Hayward et al., 2001; Germain-Lee et al., 2002; Mantovani et al., 2002; Liu et al., 2003; Weinstein et al., 2006) . Classically, the obesity in AHO is described as occurring similarly in both conditions (ALBRIGHT et al., 1952) . However, there is now evidence that the development of obesity only occurs with maternal Gαs mutations in PHP1A (Long et al., 2007) . The underlining mechanisms for the development of obesity are not yet fully understood, but it seems that adipose tissue is unlikely involved in this parent-of-origin effect, since studies have not given any evidence for Gαs imprinting in adipose tissue in humans (Mantovani et al., 2004; Germain-Lee et al., 2005) and heterozygous adipose-specific Gαs deficiency in mice results in no obvious phenotype (Chen et al., 2010 ). However, one study revealed a reduced lipolytic responsiveness to epinephrine in adipocytes from patients with PHP1A (Carel et al., 1999) and one suggested a preferential maternal expression of Gαs in adipose tissue (Yu et al., 1998) . A recent study with Gαs brain-specific knock-out mice has shown that central-nervous system specific disruption of Gαs is sufficient to produce obesity, which underlines that Gαs imprinting within parts of the central nervous system is the most likely explanation for obesity occurring in PHP1A (Chen et al., 2009) .
Although GNAS is imprinted in a tissue-specific manner, the promoter is not methylated (Kozasa et al., 1988; Liu et al., 2005) . Therefore, further studies have focused on the identification of imprinted control regions of GNAS. Promoters and first exons for transcripts encoding NESP55, Nespas, XLαs, and 1A (also known as A/B) are methylated on either the maternal or the paternal allele ( Figure 1 ). NESP55 contains a paternally methylated promoter and is exclusively maternally expressed (Hayward et al., 1998; Li et al., 2000) . In contrast, XLαs is expressed only paternally due to methylation of the maternal promoter (Hayward et al., 1998 ). An additional promoter generates paternally expressed antisense transcripts (Nespas) that cross the NESP55 exon (Li et al., 2000) . The exon 1A promoter region is located just upstream of Gαs exon 1 and contains a methylated region on the maternal allele and is thought to be a primary imprint control region, since its methylation is established during oogenesis and maintained through development (Liu et al., 2000b) . Furthermore, studies in mice have shown that paternal deletion of the exon 1A region results in reversal of Gαs imprinting with biallelic expression of Gαs (Williamson et al., 2004; Liu et al., 2005) .
In line with these findings, in pseudohypoparathyroidism type 1B (PHPIB), a form of renal parathyroid hormone resistance, maternal -specific methylation of the exon 1A is absent (Jan de Beur et al., 2003; Liu et al., 2000a) . However, exact imprinting mechanisms are not yet fully understood.
Among the possible explanations are the reciprocal regulation of the exon 1A and Gαs promoter on the paternal allele, the presence of boundary elements that insulate the Gαs promoter or a silencer element, which can bind a tissue-specific repressor and which can be inhibited by methylation Liu et al., 2000a; Weinstein, 2001) . These possible explanations are based on the assumptions of an equal allelic expression of Gαs in non-hormone target tissues and imprinting in hormone target tissues in PHP1A and involve a tissue-specific factor.
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Investigations concerning imprinting and allelic expression analysis in the past were primarily focused on hormone-specific tissues, which contribute to the hormone resistant phenotype in PHP1A. To this, allelic expression analysis was mostly performed by restriction analysis following evaluation by an imaging densitometer (Mantovani et al., 2002; Mantovani et al., 2004; Zheng et al., 2001) . This method has the disadvantage that allele-specific expression cannot be quantified accurately and subtle differences may remain unrecognized. We have recently established a method based on Pyrosequencing to quantify allele-specific transcript expression in a highly accurate manner (Sun et al., 2005) . The Pyrosequencing technique is based on the detection of released pyrophosphate (PPi) during DNA synthesis (Ronaghi et al., 1996) . An enzymatic mixture consisting of sulphurylase and luciferase converts PPi to ATP, which then drives the conversion of luciferin to oxyluciferin, yielding detectable light emission, seen as one peak, which is proportional to the amount of incorporated nucleotides (Ronaghi et al., 1998; Ahmadian et al., 2000) .
The aim of the present study was, therefore, the investigation and quantification of Gαs allelic expression using pyrosequencing in different tissues which are thought not to be imprinted since they do not contribute to the hormone resistant phenotype in PHP1A.
Material and methods

Cells and tissue samples
B lymphoblast cell lines: Human Epstein-Barr virus immortalized lymphoblasts from 24 individuals were grown in RPMI 1640 medium supplemented with 2 mM L-glutamine, 10% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin (PAA, Pasching, Austria) at 37°C in a humidified atmosphere of 5% CO 2 in air, as previously described (Siffert et al., 1995) . One day before RNA preparation, lymphoblasts were subcultured at a density of 5 -10 x 10 5 /ml into fresh medium and a total of 5-10 x 10 6 cells were used for RNA preparation. To exclude that immortalization of lymphoblasts with Epstein-Barr virus affects the imprinting status, we also used peripheral blood mononuclear cells. Peripheral blood mononuclear cells (PBMCs) from 44 healthy blood donors were isolated by Ficoll-Hypaque (Pharmacia, Erlangen, Germany) density centrifugation. In all, 1 to 2x10 8 PBMCs were used for RNA preparation. Heart tissue: Adult human right atrial specimens were 6 obtained from 94 patients undergoing cardiac surgery as described (Frey et al., 2008b) . Adipose tissue: 49 mammary adipose tissue samples were obtained from women undergoing elective mammary reduction surgery (Hauner et al., 2002) . All adipose tissue samples were immediately snap frozen in liquid nitrogen during the surgical procedure. Written informed consent was obtained from all subjects.
RNA was prepared using the RNeasy Kit obtained from Qiagen (Hilden, Germany) according to the manufacturer's instructions. RNA from mammary adipose tissue was prepared using a modified protocol. Briefly, up to 500 mg adipose tissue was mixed with 600 µl RLT lysis buffer (Qiagen, Hilden, Germany) and mechanically homogenized for 1 min followed by centrifugation at 13.000 rpm for 1 min. The supernatant was saved followed by addition of 70% ethanol. The pellet was resuspended in 300 µl RLT buffer and centrifuged for 1 min at 13.000 rpm. The supernatants from both centrifugation steps were combined, loaded onto a RNeasy column and processed following the manufacturer's instructions. RNA samples were treated with DNAse I.
All tissue and cell line samples were genotyped for the GNAS T393C polymorphism as described below. In total, we obtained 96 samples which were heterozygous for the polymorphism (lymphoblasts (Ly), n=11, peripheral blood mononuclear cells (PBMC), n=18, mammary adipose tissue (MAT), n=23 and heart tissue (HT), n=44). With those 96 heterozygous samples we measured GNAS exon 1 C allele frequency in cDNA ( Figure 3B , 3C and 6C), paternal exon 1A expression ( Figure 5C ) and maternal exon 1 expression ( Figure 7 ). Tissue and cell line samples were also genotyped for the MLH1 A655G polymorphism (rs rs1799977). In total, we obtained 88 tissue and cell line samples (Ly, n=9, RBMC, n=22, MAT, n=10 and HT, n=47) which were heterozygous for the polymorphism and used for measuring A allele frequency in cDNA.
PCR, RT -PCR and allele-specific expression
DNA was extracted from blood or tissue by standard techniques. Determination of the GNAS T393C polymorphism was performed by PCR using the primers 5´-TGTGGCCGCCATGAGCAA-3´ and 5´-7 TAAGGCCACACAAGTCGGGGT-3´. The 145 nt PCR fragment was then digested with FokI (NEB, Beverly, USA) and GNAS T393C genotypes were determined by gel electrophoresis.
To determine allele-specific expression, first-strand cDNA was synthesized from ~1 µg of total cellular RNA with oligo-dT-primers (Roche, Mannheim, Germany) by using M-MLV reverse transcriptase as recommended by the manufacturer (Invitrogen, Karlsruhe, Germany). The resulting cDNA was diluted 1:10 and 3 µl of the dilution was used for PCR.
We recently established a technique for allele-specific quantification using Pyrosequencing (Sun et al., 2005) . For GNAS allelic expression analysis, we used primers 5'-CCATGGGCTGCCTCGGGAACA-3' (exon 1) and biotinylated 5'-CGGGAGGGAAGTCAAAGTC-3' (exon 5) to amplify a 435 bp (long form) or a 390 bp (short form) fragment from cDNA derived from the different tissues which were heterozygous for the T393C polymorphism using a slowdown PCR technique including 5% DMSO (Frey et al., 2008a) . The PCR product was then subjected to pyrosequencing of the T393C polymorphism using the primer 5'-CAGTTCAGAGTGGACTACAT-3'. The allelic ratios were calculated using the Pyrosequencing software ( Figure 2 ). To determine the paternal allele in heterozygous samples, the samples were amplified with primers 5'-GCCTTGCGTGTGAGTGCACCT-3' (exon 1A) and biotinylated 5'-CGGGAGGGAAGTCAAAGTC-3' (exon 5) to amplify a 324 bp fragment with the sense primer annealing in exon 1A followed by pyrosequencing of the T393C polymorphism using the primer 5'-CAGTTCAGAGTGGACTACAT-3'.
For calculating allelic ratios of GNAS in genomic DNA we used sense primer 5'-GCCATGAGCAACCTGGTG-3' (exon 5) and biotinylated 5'-CGGGAGGGAAGTCAAAGTC-3' (exon 5) resulting in a 109 bp product followed by pyrosequencing of the T393C polymorphism using the primer 5'-CAGTTCAGAGTGGACTACAT-3'.
For calculating MLH1 allelic expression in genomic DNA and cDNA we used sense primer 5´-AGGAGAGACAGTAGC-3´ and biotinylated antisense primer 5´-CGACTAACAGCATT -3´ to amplify a 87 bp product which was than subjected to pyrosequencing of the A655G polymorphism using the sequencing primer 5´-GGACAATATTCGCTCC -3´.
Statistical methods
All data are expressed as means ± standard error of the mean (S.E.M.). Continuous variables were compared using unpaired Student's t-test or analysis of variance (ANOVA).
For allele quantification using calibration curves, calibration samples for the GNAS T393C polymorphism were prepared by mixing homozygous DNA samples at different ratios. PCR from the mixture was carried out with primers as described above. Calibration curves, represented by the plots of the measured versus the expected relative amounts of a given allele, were generated using linear regression analysis.
For heterozygous GNAS T393C samples we compared C allele ratios of DNAs. Ratios were determined using the Pyrosequencing software resulting in a mean fractional C allele frequency in DNA samples of 49.6%. The value of 49.6% is due to the measurement of the pyrosequencing technology. We used one sample t-test to determine whether maternal cDNA expression differs from the hypothetic value of 50.
Data were regarded significantly different if the affiliated p-value was below 0.05.
Results
Establishment of a method for allele-specific quantification of GNAS transcripts by
Pyrosequencing
We first investigated whether the peak heights determined by the Pyrosequencing software were actually proportional to the concentration of a specific allele. We used different ratios of DNA samples from human blood donors who were homozygous for the GNAS T393C polymorphism (CC and TT genotypes). PCR was carried out and the products were subjected to Pyrosequencing. The height of the C-peak increased with increasing CC/TT ratio in the DNA mixture. The measured peak heights were plotted against known CC/TT DNA ratios and subjected to linear regression analysis. We found an excellent linear correlation between the concentration of the "C" allele and measured C allele peak heights (y= 0.16 + 0.97x, r 2 = 0.98, p< 0.001, Figure 3A ). Therefore, this method is a suitable to quantify allele-specific transcripts of GNAS. Figure 3B ).
To investigate whether variation in C allele frequency in cDNA occurs in all of our tissues samples, we analyzed the data separately for lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue and heart tissue ( Figure 3C ). We observed in each tissue a variation in C allele frequency Finally, we determined whether another non-imprinted gene will result in a cDNA allelic expression, which is in the range of DNA allelic expression. We chose the mismatch repair gene MLH1 and the common A655G polymorphisms for allelic expression analysis, since these exchange has already been used for allelic expression studies with pyrosequencing (Kwok et al., 2010) . Figure 4 ). No differences between different cell line and tissue samples were found (data not shown).
Quantification of allelic variation for the GNAS T393C polymorphism in different tissues and cell lines
The %, Figure 5C ).
We next investigated whether unequal allelic expression might be responsible for the variation in C allele ratios of cDNA. When both alleles in a heterozygous sample were equally expressed, we expected a pyrogram as shown in Figure 2 (height of the T = 1/3 of height of the C). However, we observed different pyrograms and two representative pyrograms are shown in Figures 6A and Figure   6B . If in heterozygous sample the T allele was inherited from the father, the height of the T was less than the expected 1/3 of the height of the C allele ( Figure 6A ), so the maternally Gαs expression from the C allele was increased. When the C allele was transmitted from the father, the height of the C decreased and the height of the T allele increased, so that the T allele was higher than the expected 1/3 of the height of the C allele ( Figure 6B ). So again, maternally derived Gαs expression was increased.
Therefore, we concluded that there is an unequal allelic expression, with predominant expression from the maternal allele over the paternal allele.
We next investigated whether we could confirm these findings in all of our tissue and cell line samples (lymphoblasts (n=11), peripheral blood mononuclear cells (n=18), mammary adipose (n=23) and heart (n=44) tissue) and determined mean C allele frequency from the maternal and the paternal allele ( Figure 6C ). Mean C allele frequency from the maternal allele was above 50% in all tissues examined Fig. 7 ).
Discussion
Here we demonstrate for the first time that Gαs shows an unequal allelic expression with maternal over paternal expression in lymphoblasts, peripheral blood mononuclear cells, mammary adipose and heart tissue. Gαs is known to be imprinted in a tissue-specific manner being primarily expressed from the maternal allele in pituitary, thyroid, renal proximal tubules, gonads, and the paraventricular nucleus of the hypothalamus, all tissues contributing to hormone resistance in pseudohypoparathyroidism type 1A (PHP1A) Germain-Lee et al., 2002; Mantovani et al., 2002; Liu et al., 2003; Chen et al., 2009; Yu et al., 1998) . Gαs is biallelically expressed in most tissues and the maternal and paternal allele are supposed to contribute equally to Gαs expression Yu et al., 1998; Germain-Lee et al., 2005; Mantovani et al., 2004; Crane et al., 2009 ). However, most of these studies showing a biallelic expression equally distributed upon both alleles have not focused on detection of subtle differences between maternal and paternal expression.
We used the high sensitive Pyrosequencing method for allele expression analysis. Pyrosequencing was originally developed for the detection of single nucleotide polymorphisms, but is also used for assessing SNP allelic frequencies in DNA mixtures (Gruber et al., 2002; Wasson et al., 2002) and for detection of allelic imbalance in gene expression (Wang and Elbein, 2007) . Using this technology, we found a higher variation in C allele ratios of the GNAS T393C polymorphism in cDNA compared to human genomic DNA, while we found a comparable A allele ratio of the MLH1 A655G polymorphism in DNA and cDNA. This finding gave rise to the hypothesis of unequal allelic Gαs expression in tissues which are thought not to be imprinted. Therefore, we evaluated parental origin of Gαs in samples which were heterozygous for the GNAS T393C polymorphism by amplification of exon 1A and determination of T393C genotype. We found a monoallelic paternal expression of exon 1A, which is known to be imprinted and only expressed from the paternal allele (Liu et al., 2000b; Ishikawa et al., 1990; Liu et al., 2000a) . To this, imprinting status in the samples was confirmed.
Allelic expression analysis of exon 1 transcripts by Pyrosequencing revealed that the least expressed allele was always the same as that represented in exon 1A transcripts. Therefore, in lymphoblasts, peripheral blood mononuclear cells, mammary adipose and heart tissue we found an unequal allelic expression with maternal expression over paternal expression (ratio maternal/total*100 ± SEM: 55.7 ± 1 % in lymphoblasts, 56.1 ± 0.8 % in peripheral blood mononuclear cells, 54.5 ± 0.8 % in mammary adipose tissue and 54.1 ± 0.6 % in heart tissue).
Imprinting generally results in the expression of either the paternal or the maternal allele and corresponding silencing of the other allele (Bartolomei and Tilghman, 1997; Wood and Oakey, 2006) , but partial imprinting in which the two parental alleles are expressed to different degrees has also been described (Morison et al., 2005; Wolf et al., 2008) . In a study by Mantovani (Mantovani et al., 2002) , all tissues being imprinted and contributing to hormone resistance in PHP1A. In the same study an equal expression of Gαs from the maternal and the paternal allele in adrenal and lymphoblasts was found (Mantovani et al., 2002) . Imprinting of Gαs in the thyroid gland could be confirmed by Liu at al, showing that the majority of Gαs mRNA transcripts was derived from the maternal allele (72%).
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Another study demonstrated an equal allelic expression of Gαs in human bone and adipose tissue, although the ratio maternal/all was 53.2 %, which was, however, not statistically significant (Mantovani et al., 2004) . To investigate at which time point imprinting of Gαs occurs in embryonic development, allelic expression of Gαs in human primordial germ cells was determined. In embryonic germ cells, a ratio maternal/all of 52.6 % was found, which was not statistically significant (p=0.07).
Therefore, a biallelic expression with occurrence of Gαs imprinting 11 weeks after fertilization was assumed (Crane et al., 2009) . Taken together, some of these studies found a maternal expression of higher than 50 % in tissues, which are thought not to be imprinted, however, as the allelic expression analysis was not statistically significant. Determination of allelic expression analysis in these studies was performed by RT-PCR followed by restriction analysis and evaluation by densitometry. Here we could show that using Pyrosequencing we were able to identify unequal allelic expression with maternal over paternal expression. Therefore our data are not in contrast with the previous published studies, but rather confirm these studies showing a statistically significantly higher maternal over paternal expression in non hormone-target tissues.
Our data further support the hypothesis that adipose tissue is unlikely involved in parent-of-origin effects which lead to obesity in PHP1A. We found similar results in mammary adipose tissue, heart tissue, lymphoblasts and peripheral blood mononuclear cells. While heart tissue, lymphoblasts and peripheral blood mononuclear cells do not contribute to the hormone resistant phenotype in PHP1A (ALBRIGHT et al., 1952; Long et al., 2007; Mantovani et al., 2004; Germain-Lee et al., 2005; Chen et al., 2010) , our data are in line with the study by Chen et al., showing that central-nervous system specific disruption of Gαs is sufficient to produce obesity (Chen et al., 2009 ). However, it has to be mentioned, that allelic expression analysis was performed in adipocytes isolated from human mammary tissue. Since it is known that different adipose tissue depots (omental, subcutaneous, mammary tissue) differ in their lipolytic responsiveness and sensitivity to hormones (Richelsen et al., 1991) , we can not necessarily transfer our observations to other adipose tissue depots.
The relevance of our findings remains to be resolved. However, our findings may partly explain the molecular and clinical overlap between PHPIA and PHP1B, which has been reported in recent studies (de Nanclares et al., 2007; Mariot et al., 2008; Unluturk et al., 2008; Mantovani et al., 2010) . Whereas 14 PHPIA is caused by heterozygous loss of function mutations inherited from the mother in exons 1-13, PHPIB is caused by disruption of long-range imprinting control elements in GNAS. Typically is the loss of imprinting at the exon 1A differentially methylated region, with consequent presumed decreased Gαs expression in tissues where this protein is imprinted. Recently, four independent studies found methylation defects similar to those observed in PHPIB in patients which haven been clinically diagnosed with PHPIA, some of those patients presenting with mild features of AHO (de Nanclares et al., 2007; Mariot et al., 2008; Unluturk et al., 2008; Mantovani et al., 2010) . Furthermore, an overlap between PHPIA and PHP1B was found in terms of Gαs activity, since a reduced Gαs activity in erythrocyte membranes of patients with PHP1B compared to healthy controls was observed.
Interestingly, this effect was significantly lower in patients with some features of AHO (Zazo et al., 2011) . Therefore, it might be supposed that Gαs expression is subject to allelic bias in a larger number of tissues that currently known.
However, further studies are required to clarify these findings and exact mechanisms of Gαs imprinting.
In conclusion, our results provide the first evidence that Gαs expression shows allelic bias, with higher maternal than paternal expression, even in tissues in which heterozygous inactivating Gαs mutations do not seem to cause parent-of-origin specific hormone resistance.
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Legends
Figure 1:
Organization of the human GNAS locus. The general organization of GNAS maternal (above) and paternal (below) alleles are shown (not drawn to scale). Four alternative exons splice into exon 2 and generate four different transcripts (NESP55, XLαs, a noncoding gene product from exon 1A and Gαs).
Arrows indicate transcription start sites. Also marked is the T393C polymorphism located in exon 5.
Figure 2:
Expected Pyrosequencing result by amplification of exon 1 obtained from cDNAs which were heterozygous for the GNAS T393C polymorphism. Peak heights were quantified using the Pyrosequencing software.
PCR products were amplified with PCR primers located in exon 1 (Sense Primer) and exon 5 (Antisense Primer) as indicated with arrows. We than used the pyrosequencing technique to determine allelic expression. We used the sequencing primer 5'-CAGTTCAGAGTGGACTACAT-3' in exon 5, which has it 3´-end directly at the T393C polymorphism and the nucleotide dispensation order (G-T-C-G-T-G-A-G-T). The first nucleotide (G) does not result in light emission, since these G will not be synthesized to the cDNA-strand, because it does not conform to the corresponding GNAS exon 5 sequence. The second nucleotide presents a "T". Since we used samples heterozygous for the T393C polymorphism this nucleotide leads to light emission, however, peak height has half height compared to homozygous T allele carrier. The third nucleotide is a "C". This will lead to a peak, which is three times higher than the peak of the nucleotide 2, since light emission will release from the heterozygous "C" and the following homozygous C in the GNAS exon 5 sequence. The incorporated G at position 4 does not conform to the GNAS exon 5 sequence, and does therefore not result in light emission. The next incorporated nucleotides (5-9) conform to the further GNAS exon 5 sequence and therefore lead to light emission classically observed in homozygous samples.
Shown is the expected Pyrogram when both alleles (C and T) were equally expressed: height of the T = 1/3 of height of the C. were heterozygous for the GNAS T393C polymorphism. Peak heights were quantified using the Pyrosequencing software. PCR products were amplified with PCR primers located in exon 1A (Sense Primer) and exon 5 (Antisense Primer) as indicated. "E" corresponds to enzyme and "S" to substrate.
Both components are dispensated before nucleotide are incorporated to the reaction. "G", "C", "A"
and "T" correspond to the nucleotide guanine, cytosine, adenosine and thymine.
(A) Since the exon 1A is only expressed from the paternal allele, the pyrograms show a 100% allelic expression from the paternal C allele. The first incorporated "T" corresponding to the T393C polymorphism does not lead to light emission, since a 100% expression from paternal C is comparable to homozygous T393C CC genotypes.
(B) Observed pyrogram when the T allele is inherited from the father: 100% allelic expression from the paternal T allele. The first incorporated "T" and "C" evoke an equal peak height, since a 100% expression from the paternal T in comparable to homozygous T393C TT genotypes and therefore equal to the next incorporated, homozygous "C".
(C) Maternal imprinting of exon 1A in the 96 tissues (lymphoblasts (Ly), n=11, peripheral blood mononuclear cells (PBMC), n=18, mammary adipose tissue (MAT), n=23 and heart tissue (HT), n=44) investigated. As expected, we found a monoallelic paternal expression of exon 1A, which is methylated on the maternal allele (ratio paternal/total ± SEM: 98 ± 0.3 %, 95 % CI 97.4 % -98.6 %).
Figure 6:
Observed Pyrosequencing results by amplification of exon 1 obtained from cDNAs which were heterozygous for the GNAS T393C polymorphism. Peak heights were quantified using the Pyrosequencing software.
(A) Shown is a representative observed pyrogram when the T allele was inherited from the father. As explained in the figure legend to figure 2, we expected that the height of the T would be 1/3 of the 22 height of the C. However, we observed that the height of the T was less than 1/3 of the height of the C allele. Therefore, the expression from the maternal C allele was increased.
(B) Shown is a representative observed pyrogram when the C allele was inherited from the father. The height of the T was higher than the expected 1/3 of the height of the C allele. Therefore, expression from the maternal T allele was increased.
"E" corresponds to enzyme and "S" to substrate. Both components are dispensated before nucleotide are incorporated to the reaction. 23 Highlights:
• The human GNAS gene is imprinted in a tissue-specific manner • Exact mechanisms of Gαs imprinting are not yet fully understood • We analysed allelic expression using the highly sensitive Pyrosequencing technology
• We found an unequal allelic expression in different non-imprinted tissues • This phenomenon may be a general feature existing in all tissues
